Clinical Trial Update: A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

Phase 3 open-label study assessing safety and tolerability of vilazodone in major depressive disorder completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vilazodone (vilazodone)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-09-25